PharmaSources E-Newsletter January 2022 Issue 1

[Pharma Sources]

View this e-mail (http://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGRu8T.H1tTA1NLof5GthaGxsZkBAAA45)  (http://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGRu8T.H1tTA1NLof5GthaGxsZkBAAA45)online

E-Newsletter 
January 2022 

 (https://www.pharmasources.com/register?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)
Home (https://www.pharmasources.com/?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)
Products (https://www.pharmasources.com/products?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)
Suppliers (https://www.pharmasources.com/suppliers?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)
News (https://www.pharmasources.com/news?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)

Editor's Pick

 (https://www.pharmasources.com/news/74941.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)Access to Health Insurance Directory, and Similarities and Differences of System Development among Foreign Countries and China
With the increasing of the elderly population in China, the reduction of drug price is a major trend, But the falling prices may not be friendly to new drugs.
Read More (https://www.pharmasources.com/news/74941.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)

 (https://efile.imsinoexpo.com/efile/CPhI/Yingqi/2022_PharmaSources%20Sponsorship%20Package.pdf)More Industry Insights
A New Record of the Approval of the New Chinese Medicine with the Reform of Review and Approval Systems of the Traditional Chinese Medicine (https://www.pharmasources.com/news/75084.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)Fierce Competition of R&D of KRAS G12C Inhibitors (https://www.pharmasources.com/news/75085.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)Active Arrangement of Chinese Pharma Companies in the Further Exploration of Aurora Kinase Inhibitors (https://www.pharmasources.com/news/75070.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)

Hot Products

 (https://www.pharmasources.com/products/butylated-hydroxytoluene-bht-274715.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)Butylated hydroxytoluene
BHT
 (https://www.pharmasources.com/products/l-arabinose-2523.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)L-Arabinose
 
 (https://www.pharmasources.com/products/tripotassium-glycyrrhizinate-85378.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)Tripotassium
Glycyrrhizinate

 (https://www.pharmasources.com/products/b29-50ml-pp-plastic-injection-vials-18612.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)B29 50ml pp
plastic injection vials
 (https://www.pharmasources.com/products/filter-leakage-tesk-261134.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)filter leakage tesk
 
 (https://www.pharmasources.com/products/osmometer-274876.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)osmometer
 

Source More Products (https://www.pharmasources.com/products?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)

 (https://www.pharmasources.com/news/74223.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114)We Want You!

Become a Pharma Product Writer (https://www.pharmasources.com/news/64953.html?utm_source=newsletter&utm_medium=email&utm_campaign=enedmPSenews0114) for PharmaSources.com to Reach the Right Audience

Customer Service
(+86) 400 610 1188
PharmaSources at imsinoexpo.com (mailto:PharmaSources at imsinoexpo.com)

unsubscribe (http://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tsYGRu8T.H1tTA1NLof5GthaGxsZkBAAA45&Z=-1970497566)
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20220114/a446378c/attachment-0001.html>